[HTML][HTML] Systematic review and meta-analysis of damage associated molecular patterns HMGB1 and S100B in schizophrenia

M Mackey, L Holleran, G Donohoe… - Psychiatry …, 2022 - ncbi.nlm.nih.gov
Objective Immune system dysregulation is hypothesised to be central to the
aetiopathogenesis of schizophrenia; however, the role of sterile inflammation remains …

Advanced biomarkers of hepatotoxicity in psychiatry: a narrative review and recommendations for new psychoactive substances

A Golub, M Ordak, T Nasierowski… - International Journal of …, 2023 - mdpi.com
One of the factors that increase the effectiveness of the pharmacotherapy used in patients
abusing various types of new psychoactive substances (NPSs) is the proper functioning of …

Establishment of a schizophrenia classifier based on peripheral blood signatures and investigation of pathogenic miRNA-mRNA regulation

M Jin, Y Liu, G Hu, X Li, N Jia, X Cui, Z Li, L Ai… - Journal of Psychiatric …, 2023 - Elsevier
To date, the diagnosis of schizophrenia (SCZ) mainly relies on patients' or guardians' self-
reports and clinical observation, and the pathogenesis of SCZ remains elusive. In this study …

Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls

S Chen, M Gou, W Chen, M Xiu, H Fan, Y Tan… - Frontiers in …, 2022 - frontiersin.org
Innate immune components involved in host defense have been implicated in schizophrenia
(SCZ). However, studies exploring their clinical utility in SCZ diagnosis are limited. The main …

Serum HMGB1 and Beclin 1 Levels in Patients with a Diagnosis of Schizophrenia

S Yıldız, AK Kılıçaslan, BS Emir… - Turkish Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Objective: It is known that inflammation plays a role in the etiopathogenesis of
schizophrenia. In this study, we examined high mobility group box 1 protein (HMGB1) and …

[HTML][HTML] High Mobility Group Box 1 Levels as an Inflammatory Mediator in Bipolar Mania

A Kara, ÖD Balaban, B Çınar, ST Oluğ… - Archives of …, 2024 - ncbi.nlm.nih.gov
Methods: A single-center, observational, case-control study was conducted. Thirty-five
patients with BD in manic episodes and 35 HC were assessed. Young Mania Rating Scale …

May high mobility group box protein-1 be a biomarker for major depressive disorder?

AE Köse, T Turan, E Kilic - Journal of Neuroimmunology, 2024 - Elsevier
Abstract High Mobility Group Box Protein-1 (HMGB1), which has proinflammatory properties,
is known to be involved in psychiatric disorders as far as we know, there are only one …

[PDF][PDF] Şizofreni Tanılı Hastalarda Serum HMGB1 ve Beklin 1 Düzeyleri.

S YILDIZ, A KAZĞAN KILIÇASLAN… - Turk Psikiyatri …, 2024 - turkpsikiyatri.com
Amaç: Şizofreni etiyopatogenezinde inflamasyonun rol oynadığı bilinmektedir. Bu çalışmada
şizofreni tanılı hastalarda yüksek mobilite grup kutusu 1 protein (HMGB1) ve Beklin 1 …

A scope systematic review to clarify immune response to tobacco in Buerger

K Ahmadi, N Khaghanzadeh, SR Mirlohi, SA Hosseini… - 2024 - researchsquare.com
Background Progressive Thromboangiitis Obliterans (TAO) is a progressive and segmental
inflammatory disorder known as Buerger's disease that affects the medium and small …

[PDF][PDF] Bipolar Manide Enflamasyon Belirteci Olarak High Mobility Grup 1 Protein

A KARA, ÖD BALABAN, B ÇINAR, ST OLUĞ, C KILIÇ… - 2023 - noropsikiyatriarsivi.com
Introduction: High mobility group box 1 protein (HMGB1) is a member of the molecular family
known as damage-associated molecular patterns, which is implicated to have a role in …